In the study that assessed IDH-genotypes [20], it was found that a model comprising CE-T1WI + T2-FLAIR + ADC MRI sequences showed the best performance in predicting IDH for low- and high-risk groups in grade II and grade III-IV astrocytomas. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).